Healthy Skepticism Library
Items published in 2009
There are 1968 items in the Healthy Skepticism Library that were published in 2009.
Page 19 of 20 pages « First < 17 18 19 20 >
HSL14949
Rubenstein S.
Medtronic Pays Surgeon ‘$20,000 or More’ — Much, Much More
The Wall Street Journal 2009 Jan 16
http://blogs.wsj.com/health/2009/01/16/medtronic-pays-surgeon-20000-or-more-much-much-more/
HSL17472
Armstrong D, Burton TM
Medtronic Paid Researcher More Than $20,000 -- Much More
The Wall Street Journal 2009 Jan 16
http://online.wsj.com/article/SB123206035479087601.html?mod=googlenews_wsj
HSL17473
Fauber J
Medical device maker paid UW surgeon $19 million
The Journal Sentinel 2009 Jan 16
http://www.jsonline.com/news/wisconsin/37748554.html
HSL17475
Andrews A
Scrutiny of Doctor-Pharma Ties Leads to Change
ProPublica 2009 Jan 16
http://www.propublica.org/article/scrutiny-of-doctor-pharma-ties-leads-to-change-090116
HSL14868
Angell M.
Drug Companies & Doctors: A Story of Corruption
The New York Review of Books 2009 Jan 15
http://www.nybooks.com/articles/22237
HSL14904
Harris G.
Lilly Said to Be Near $1.4 Billion U.S. Settlement
The New York Times 2009 Jan 15
http://www.nytimes.com/2009/01/15/business/15drug.html
HSL14921
Cronin Fisk M, O’Reilly C.
Lilly to Pay Biggest Fine Ever to End Zyprexa Probe
Bloomberg.com 2009 Jan 15
http://www.bloomberg.com/apps/news?pid=20601087&sid=aGDAxYMRGIw0
HSL14922
Richwine L.
U.S. lets drugmakers advise doctors on unapproved uses
Reuters 2009 Jan 15
http://www.reuters.com/article/email/idUSTRE50B5GK20090112
HSL14945
US Department of Justice
Pharmaceutical Company Eli Lilly To Pay Record
US Department of Justice 2009 Jan 15
http://www.usdoj.gov/usao/pae/News/Pr/2009/jan/lillyrelease.pdf
HSL14951
Frankston Lorin J, Lauerman J.
Harvard Medical School to Review Drug Research Ethics
Bloomberg.com 2009 Jan 15
http://www.bloomberg.com/apps/news?pid=20601103&sid=aD6RpDNyYKko&refer=us
HSL14931
Mundy A, Favole J.
Glaxo's Emails on Avandia Reveal Concern
The Wall Street Journal 2009 Jan 14
http://online.wsj.com/article/SB123190610976680477.html?mod=googlenews_wsj
HSL14934
O'Riordan M.
Reps Can Distribute Info About Off-Label Drug and Device Use, Says the FDA
Medscape Today 2009 Jan 14
http://www.medscape.com/viewarticle/586801?src=mp&spon=17&uac=36327PX
HSL15089
Goldacre B.
Pay to play?
Bad Science 2009 Jan 14
http://www.badscience.net/2009/02/pay-to-play/
HSL14902
Fleg A.
Unbranding the doctor’s office
The New Mexico Independent 2009 Jan 13
http://newmexicoindependent.com/14749/unbranding-the-doctors-office
HSL14925
Not What We Call Due Diligence
The New York Times 2009 Jan 13
http://www.nytimes.com/2009/01/13/opinion/13tue2.html?_r=1
HSL14926
Staton T.
Suddenly, everyone's a DTC critic
Fierce Pharma 2009 Jan 13
http://www.fiercepharma.com/story/suddenly-everyones-dtc-critic/2009-01-13
HSL14947
Meier B.
Device Maker Sues a Doctor Who Called Its Product Flawed
The New York Times 2009 Jan 13
http://www.nytimes.com/2009/01/14/health/research/14heartside.html?_r=2&ref=research
HSL14950
Singer N.
Love the Long Eyelashes. Who’s Your Doctor?
The New York Times 2009 Jan 13
http://www.nytimes.com/2009/01/14/health/research/14lash.html?_r=1&emc=eta1
HSL14943
Finucane TE.
Men, androgen deficiency, and pharmaceutical promotion.
Arch Intern Med. 2009 Jan 12; 169:(1):88
http://archinte.ama-assn.org/cgi/content/full/169/1/88
HSL14959
Fauber J.
Drug firms wine, dine and pay up for doctors' speeches
Journal Sentinel 2009 Jan 12
http://www.jsonline.com/features/health/37421114.html
HSL14966
Alonso-Zaldivar R.
Report: FDA screening of researchers is unreliable
The Associated Press 2009 Jan 12
http://www.statesman.com/search/content/news/stories/nation/01/12/0112fdaconflicts.html
HSL14923
Campbell D.
NHS patients to get better drug access
Guardian.co.uk 2009 Jan 11
http://www.guardian.co.uk/society/2009/jan/11/health-nhs-pharmaceuticals-drugs
HSL14958
Fauber J.
Doctors face pressure to disclose all side pay
Journal Sentinel 2009 Jan 11
http://www.jsonline.com/features/health/37397284.html
HSL14887
Ramshaw E.
Bills seek disclosure of pharmaceutical companies' payments to doctors
Dallas News.com 2009 Jan 10
http://www.dallasnews.com/sharedcontent/dws/dn/latestnews/stories/011009dntexpharma.3e0964b.html
HSL14908
Rice M.
Paying the piper
The Sydney Morning Herald 2009 Jan 10
http://www.smh.com.au/news/national/paying-the-piper/2009/01/09/1231004286970.html
HSL14903
Mundy A.
Regulator's Clothing: Drug Industry Critic Joins the FDA
The Wall Street Journal 2009 Jan 9
http://online.wsj.com/article/SB123145489435265929.html?mod=googlenews_wsj
HSL14920
Harris G.
Medical Journal Changes Its Policy After Criticism by Group
The New York Times 2009 Jan 9
http://www.nytimes.com/2009/01/09/us/09journal.html?_r=1
HSL14954
Apotex Inc.: A Corporation Above the Courts?
Canadian Association of University Teachers 2009 Jan 9
http://www.caut.ca/pages.asp?page=734
HSL14886
Landefeld CS, Steinman MA.
The Neurontin Legacy: Marketing Misinformation and Manipulation
The New England Journal of Medicine 2009 Jan 8; 360:(2):103
http://content.nejm.org/cgi/content/full/360/2/103
HSL14889
Lentini NM.
Wyeth Ads Encourage: 'Say Yes To Advil'
Marketing Daily 2009 Jan 8
http://www.mediapost.com/publications/?fa=Articles.san&s=97981&Nid=51055&p=448587
HSL14890
Thomaselli R.
'Morning-After Pill' Catches Flak for MTV.com Ad
The Advertising Adage 2009 Jan 8
http://adage.com/article?article_id=133632
HSL14891
Connolly C.
With More Oversight on the Horizon, Drugmakers Work to Polish Image
The Washington Post 2009 Jan 8
http://www.washingtonpost.com/wp-dyn/content/article/2009/01/07/AR2009010703869.html
HSL14913
Herper M.
The Value Of New Drugs Is Dropping
Forbes.com 2009 Jan 8
http://www.forbes.com/2009/01/07/pharmaceuticals-sales-biz-healthcare-cx_mh_0108drugssales.html
HSL14914
Rubenstein S.
Drug Industry Hustles to Blunt Democratic Strikes
The Wall Street Journal Blog 2009 Jan 8
http://blogs.wsj.com/health/2009/01/08/drug-industry-hustles-to-blunt-democratic-strikes/
HSL14924
Sweney M.
Sex drug poster ads to be taken down
Guardian.co.uk 2009 Jan 8
http://www.guardian.co.uk/media/2009/jan/08/sex-drug-ads-taken-down
HSL14960
Monash D.
Time to put pharmacists under the microscope
Crikey 2009 Jan 8
http://www.crikey.com.au/Politics/20090108-Why-its-time-to-put-pharmacy-under-scrutiny.html
HSL14900
Hirji KF.
No short-cut in assessing trial quality: a case study.
Trials 2009 Jan 7; 10:(1):
www.trialsjournal.com/content/10/1/1
HSL14901
Gøtzsche PC.
Readers as research detectives
Trials 2009 Jan 7; 10:(1):
www.trialsjournal.com/content/10/1/2
HSL14915
Hopkins Tanne J.
US university psychiatrist loses chairmanship over drug company payments..
BMJ. 2009 Jan 6; 338:a3188:
http://www.bmj.com/cgi/content/extract/338/jan05_3/a3188
HSL14880
Taylor L.
German govt 'to force drugmakers to sell through wholesalers'
Pharma Times 2009 Jan 5
http://www.pharmatimes.com/WorldNews/article.aspx?id=15023&src=EWorldNews
HSL14881
Stepping into the therapeutics void.
Coombes R.
BMJ. 2009 Jan 5; 338:a3179:
http://www.bmj.com/cgi/content/full/338/jan05_2/a3179
HSL14882
Pharmaceutical Research and Manufacturers of America Enacts New Voluntary Guidelines on Physician Gifting Practices
Kaiser Daily Health Policy Report. 2009 Jan 5
http://www.kaisernetwork.org/daily_reports/rep_index.cfm?DR_ID=56245
HSL14885
Change in FDA's ethical guidelines for clinical trials troubling: Lancet
CBC News 2009 Jan 5
http://www.cbc.ca/health/story/2009/01/05/fda.html
HSL14910
Coombes R.
Stepping into the therapeutics void.
BMJ. 2009 Jan 5; 338:a3179:
http://www.bmj.com/cgi/content/extract/338/jan05_2/a3179
HSL14916
New Year Resolution: Stand Up to Healthcare Marketing Hypocrisy!
Trusted.MD 2009 Jan 5
http://trusted.md/blog/hippocrates/2009/01/06/new_year_resolution_stand_up_to_healthcare_marketing_hypocrisy
HSL14918
Staton T.
Shrinking sales forces face constraints
Fierce Pharma 2009 Jan 5
http://www.fiercepharma.com/story/shrinking-sales-forces-face-constraints/2009-01-03
HSL14919
Staton T.
Congress mandates disclosure
Fierce Pharma 2009 Jan 5
http://www.fiercepharma.com/story/show-us-yours-well-show-you-ours/2009-01-03
HSL14883
No Mugs, but What About Those Fees
The New York Times 2009 Jan 4
http://www.nytimes.com/2009/01/05/opinion/05mon1.html
HSL17010
Silverman E
Drugging Kids for Profit
Portfolio.com 2009 Jan 4
http://www.portfolio.com/industry-news/health-care/2010/01/04/drugging-kids-for-profit/index1.html
HSL14909
Tyrer P, Kendall T.
The spurious advance of antipsychotic drug therapy
The Lancet 2009 Jan 3; 373:(9657):4-5
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(08)61765-1/fulltext
HSL14911
Kimmelman J, Weijer C, Meslin EM.
Helsinki discords: FDA, ethics, and international drug trials
The Lancet 2009 Jan 3; 373:(9657):13-4
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(08)61936-4/fulltext
HSL14869
Pringle E.
SSRI Pushers under Fire
Scoop 2009 Jan 2
http://www.scoop.co.nz/stories/HL0901/S00008.htm
HSL14917
AMSA Applauds Pharma Ban; Continues to Call for Federal Regulation
Pharma Live 2009 Jan 2
http://pharmalive.com/news/index.cfm?articleID=595275
HSL14841
Poole D, Bertolini G, Garattini S.
Errors in the approval process and post-marketing evaluation of drotrecogin alfa (activated) for the treatment of severe sepsis.
Lancet Infect Dis 2009 Jan; 9:(1):67-72
http://linkinghub.elsevier.com/retrieve/pii/S1473-3099(08)70306-2
HSL14893
Kyle GJ, Nissen LM, Tett SE
The Australian rise of esomeprazole-was expenditure on samples a contributor?
Pharmacoepidemiol Drug Saf. 2009 Jan; 18:(1):62-8
http://www3.interscience.wiley.com/journal/121587742/abstract?CRETRY=1&SRETRY=0
HSL14907
Clauson KA, Khanfar NM, Polen HH, Gibson F.
Nurse prescribers' interactions with and perceptions of pharmaceutical sales representatives.
J Clin Nurs 2009 Jan; 18:(2):228-33
http://www3.interscience.wiley.com/journal/121562111/abstract
HSL15001
Levinson DR
The Food and Drug Administration’s Oversight of Clinical Investigator’s Financial Information
: FDA 2009 Jan
http://www.oig.hhs.gov/oei/reports/oei-05-07-00730.pdf
HSL15017
Thawani V, Gharpure K.
Monitoring misuse of the WHO name and emblem in medicine promotion in India
Indian Journal of Medical Ethics 2009 Jan-Mar; 17:(1):epub
http://www.ijme.in/171ar10
HSL15048
Klemperer D.
[Self-help groups conflicts of interest through sponsoring by the pharmaceutical industry].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2009 Jan; 52:(1):71-6
http://www.springerlink.com/content/92x3337327075725/
HSL15054
Shankar PR, Piryani RM
Medical education and medical educators in South Asia - a set of challenges.
J Coll Physicians Surg Pak. 2009 Jan; 19:(1):52-6
http://www.ncbi.nlm.nih.gov/pubmed/19149982
HSL15234
Spake DF, Joseph M, Finney RZ.
Urban senior citizens' versus rural consumers' views of DTC advertising: A preliminary investigation
Journal of Medical Marketing 2009 Jan; 9:(1):21–28
http://www.palgrave-journals.com/jmm/journal/v9/n1/abs/jmm200817a.html
HSL15235
Kelly D, Rupert E.
Professional emotions and persuasion: Tapping non-rational drivers in health-care market research
Journal of Medical Marketing 2009 Jan; 9:(1):3–9
http://www.palgrave-journals.com/jmm/journal/v9/n1/abs/jmm200828a.html
HSL15322
Joseph JN, Deaton D, Ehsan H, Bonanno MA
Enforcement related to off-label marketing and use of drugs and devices: where have we been and where are we going?
J Health Life Sci Law 2009 Jan; 2:(2):73-108
http://www.ncbi.nlm.nih.gov/pubmed/19288889
HSL15439
Hall J, Noyce P, Cantrill JHow do district nurses choose which products to prescribe.
How do district nurses choose which products to prescribe?
Br J Community Nurs. 2009 Jan; 14:(1):12,
http://www.ncbi.nlm.nih.gov/pubmed/19363864
HSL17087
Heinemann L.
Trust: Need for an Improved Communication between the Public World and the Pharmaceutical Companies.
J Diabetes Sci Technol 2009 Jan; 3:(1):210-2
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2769856/?tool=pubmed
HSL14929
Tattersall MHN, Dimoska A, Gan K.
Patients expect transparency in doctors’ relationships with the pharmaceutical industry
eMJA 2009; 2:65-68
http://www.mja.com.au/public/issues/190_02_190109/tat10368_fm.html
HSL14930
Olver IN, Haines IE.
What changes are needed to the current direction and interpretation of clinical cancer research to meet the needs of the 21st century?
eMJA 2009; 190:(2):74-77
http://www.mja.com.au/public/issues/190_02_190109/olv10224_fm.html
HSL14946
Loukas E.
Sales Through Retail Pharmacies (Twelve months to November 2008*)
IMS 2009
http://view.respond.imshealth.com/?j=fe8a12757c66067471&m=fef31377726304&ls=fdf51577706d027d77137070&l=fe9c1570746204787
HSL14991
Sweet M.
Pharmaceutical marketing and the internet
Australian Prescriber 2009; 23:2-4
http://www.australianprescriber.com/magazine/32/1/2/4/
HSL15040
Stockigt JR.
The quality of medication information in Australia: the need for more clinical expertise and accountability
eMJA 2009; 190:(3):110-111
http://www.mja.com.au/public/issues/190_03_020209/sto11172_fm.html
HSL15045
Mansell P, Read J.
Posttraumatic stress disorder, drug companies, and the internet.
J Trauma Dissociation 2009; 10:(1):9-23
http://www.ncbi.nlm.nih.gov/pubmed/19197709
HSL15046
Alkhateeb FM, Khanfar NM, Clauson KA.
Characteristics of physicians who frequently see pharmaceutical sales representatives.
J Hosp Mark Public Relations 2009; 19:(1):2-14
http://www.ncbi.nlm.nih.gov/pubmed/19197653
HSL15047
Polen HH, Khanfar NM, Clauson KA.
Impact of Direct-to-Consumer Advertising (DTCA) on Patient Health-Related Behaviors and Issues.
Health Mark Q. 2009; 26:(1):42-55
http://www.ncbi.nlm.nih.gov/pubmed/19197587
HSL15165
Elshaug AG, Moss JR, Littlejohns P, Karnon J, Merlin TL, Hiller JE.
Identifying existing health care services that do not provide value for money
Med J Aust 2009; 190:(5):269-273
http://www.mja.com.au/public/issues/190_05_020309/ell10663_fm.html
HSL15177
PriceWaterhouseCoopers
Pharma 2020: Marketing the future: Which path will you take?
: PriceWaterhouseCoopers 2009
http://www.pwc.com/Extweb/pwcpublications.nsf/docid/B1221EC9D057309F852575610076732C
HSL15182
Aronson JK, Price D, Ferner RE
A strategy for regulatory action when new adverse effects of a licensed product emerge.
Drug Saf 2009; 32:(2):91-8
http://www.ncbi.nlm.nih.gov/pubmed/19236116?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
HSL15262
Leo J, Lacasse JR.
Consumer advertisements of medications for ADHD
Tamimi S, Leo J. Rethinking ADD: From Brain To Culture. New York: Palgrave Macmillan 2009
http://www.amazon.com/Rethinking-ADHD-Culture-Sami-Timimi/dp/0230507123
HSL15382
Abelson J, Collins PA.
Media Hyping and the 'Herceptin Access Story': An Analysis of Canadian and UK Newspaper Coverage
Healthcare Policy / Politiques de Santé 2009; 4:(3):e113-e128
http://www.longwoods.com/product.php?productid=20474&cat=582
HSL15505
Mulki JP, Jaramillo JF, Locander WB.
Critical Role of Leadership on Ethical Climate and Salesperson Behaviors
Journal of Business Ethics 2009; (86):125-141
http://www.springerlink.com/content/355705k570264364/
HSL15524
Jureidini J
How do we Safely Treat Depression in Children, Adolescents and Young Adults?
Drug Saf 2009; 32:(4):275-82
http://www.ncbi.nlm.nih.gov/pubmed/19388719
HSL15541
Rod M, Saunders S.
The informative and persuasive components of pharmaceutical
International Journal of Advertising 2009; 28:(2):313-349
http://www.internationaljournalofadvertising.com/
HSL15568
Manhattan Research
The Absolute, Relative, and Incremental ROI of DTC Digital Marketing
: Manhattan Research 2009
http://www.manhattanresearch.com/files/White_Papers/The_Absolute_Relative_and_Incremental_ROI_of_DTC_Digital_Marketing.pdf
HSL15625
Molnar FJ, Man-son-hing M, Hutton B, Fergusson DA.
Have last-observation-carried-forward analyses caused us to favour more toxic dementia therapies over less toxic alternatives? A systematic review
Open Medicine 2009; 3:(2):
http://www.openmedicine.ca/article/view/245/230
HSL15626
Altman DG.
Missing outcomes in randomized trials: addressing the dilemma
Open Medicine 2009; 3:(2):
http://www.openmedicine.ca/article/view/323/232
HSL15635
Food and Drug Administration
RE: NDA #20-449 Taxotere® (docetaxel) Injection Concentrate, Intravenous Infusion (IV)
: Food and Drug Administration 2009
http://www.fda.gov/cder/warn/2009/Taxotere_Letter.pdf
HSL15700
Jureidini JN, McHenry LB.
Key Opinion Leaders and Paediatric Antidepressant Overprescribing
Psychotherapy and Psychosomatics 2009; 78:(4):197-201
http://www.online.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&ArtikelNr=214440&Ausgabe=248735&ProduktNr=223864&filename=214440.pdf
HSL15785
Vandereycken W.
[An analysis of advertisements for psychotropic drugs in the Dutch Journal of Psychiatry ('Tijdschrift voor Psychiatrie')].
Tijdschr Psychiatr. 2009; 51:(6):407-11
http://www.tijdschriftvoorpsychiatrie.nl/en/tijdschrift/artikel/TVPart_2796
HSL15786
Greene JA, Podolsky SH
Keeping modern in medicine: pharmaceutical promotion and physician education in postwar america.
Bull Hist Med 2009; 83:(2):331-77
http://muse.jhu.edu/journals/bulletin_of_the_history_of_medicine/v083/83.2.greene.html
HSL15834
Liang BA, Mackey T.
Searching for safety: addressing search engine, website, and provider accountability for illicit online drug sales.
Am J Law Med. 2009; 35:(1):125-84
http://www.ncbi.nlm.nih.gov/pubmed/19534258
HSL15881
Rojas M.
Price discrimination by pharmaceutical companies across Central American countries
International Journal of Pharmaceutical and Healthcare Marketing 2009; 3:(2):118 - 136
http://www.emeraldinsight.com/Insight/viewContentItem.do?contentType=Article&contentId=1796048
HSL15882
Kalyanaram GK.
The endogenous modeling of the effect of direct-to-consumer advertising in prescription drugs
International Journal of Pharmaceutical and Healthcare Marketing 2009; 3:(2):137 - 148
http://www.emeraldinsight.com/Insight/viewContentItem.do?contentType=Article&contentId=1796049
HSL15963
Greenland S.
Accounting for uncertainty about investigator bias: disclosure is informative: How could disclosure of interests work better in medicine, epidemiology and public health?
Journal of Epidemiology and Community Health 2009; 63:593-598
http://jech.bmj.com/cgi/content/extract/63/8/593?etoc
HSL15964
Michaels D.
Addressing conflict in strategic literature reviews: disclosure is not enough: How could disclosure of interests work better in medicine, epidemiology and public health?
J Epidemiol Community Health 2009; 63:599-600
http://jech.bmj.com/cgi/content/extract/63/8/599?etoc
HSL15965
Weed DL.
Conflicts of interest: How could disclosure of interests work better in medicine, epidemiology and public health?
J Epidemiol Community Health 2009; 63:(8):601-602
http://jech.bmj.com/cgi/content/extract/63/8/601?etoc
HSL15966
Spelsberg A, Martiny A, Schoenhoefer PS.
Is disclosure of potential conflicts of interest in medicine and public health sufficient to increase transparency and decrease corruption?: How could disclosure of interests work better in medicine, epidemiology and public health?
J Epidemiol Community Health 2009; 63:(8):603-605
http://jech.bmj.com/cgi/content/extract/63/8/603?etoc
HSL15967
Wagner W, McGarity T.
Regulatory reinforcement of journal conflict of interest disclosures: How could disclosure of interests work better in medicine, epidemiology and public health?
J Epidemiol Community Health 2009; 63:(8):606-607
http://jech.bmj.com/cgi/content/extract/63/8/606?etoc
HSL15968
Marcovitch H.
How do potential conflicts of interest confuse medicine and public health? How could disclosure of interests work better in medicine, epidemiology and public health?
J Epidemiol Community Health 2009; 63:(8):608-609
http://jech.bmj.com/cgi/content/extract/63/8/608?etoc
HSL15970
12th Annual Survey on Consumer Reaction to DTC Advertising of Prescription Drugs Reveals: Nearly 50% of Online Consumers Report Health Videos a Top Resource
Pharma Live 2009
http://pharmalive.com/news/index.cfm?articleID=638484
HSL15987
Bove AA.
President's Page: Relations With Industry: Thoughts on Claims of a Broken System
J Am Coll Cardiol 2009; 54:(2):177-179
http://content.onlinejacc.org/cgi/content/full/54/2/177
HSL16018
O'Meara A.
Chasing Medical Miracles - The Promise and Perils of Clinical Trials
: Walker Books 2009
http://www.walkerbooks.com/books/catalog.php?key=818
Page 19 of 20 pages « First < 17 18 19 20 >
